South Korea vs Middle East, North Africa, Afghanistan & Pakistan (excluding high income): Immunization, HepB3
Immunization, HepB3 over time
- South Korea
- Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
How they compare
South Korea currently reports 97.0% against 83.7% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income), a difference of 13.3%.
That makes South Korea's figure about 1.2 times Middle East, North Africa, Afghanistan & Pakistan (excluding high income)'s.
Across all 30 years both countries report, South Korea has been ahead every year.
South Korea ranks 26th and Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 27th of 188 countries.
South Korea has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | South Korea | Middle East, North Africa, Afghanistan & Pakistan (excluding high income) | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 90.0% | 29.2% | 60.8% | South Korea |
| 2000s | 93.4% | 61.6% | 31.8% | South Korea |
| 2010s | 98.0% | 79.5% | 18.5% | South Korea |
| 2020s | 97.4% | 82.6% | 14.8% | South Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, South Korea or Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
- South Korea, at 97.0% against 83.7% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income) as of 2024.
- What is the difference in immunization, hepb3 between South Korea and Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
- 13.3%, with South Korea ahead.
- How many years of comparable data are there for South Korea and Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
- 30 years are reported by both, from 1995 to 2024.
- How do South Korea and Middle East, North Africa, Afghanistan & Pakistan (excluding high income) rank globally for immunization, hepb3?
- South Korea ranks 26th and Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 27th of 188 countries.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.